 |
ProductsAntisoma has a diverse portfolio of products in development. Our products target tumours by several different mechanisms and are intended for the treatment of a range of cancers 
Read more
|
Latest news
| 16/06/2008 | Antisoma announces AS1413 (Xanafide) presentation at EHA |   |
| 11/06/2008 | Antisoma completes acquisition of Xanthus Pharmaceuticals Inc. |   |
| 09/06/2008 | EGM resolutions passed | |
In focus
Share price
| 21.00 GBp |  0.00 |
| Date: | 04/07/2008 |
